1. Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication
- Author
-
Massimo Bovenzi, Lory Santarelli, Matteo Valentino, Federica Monaco, Jiri Neuzil, Marco Tomasetti, Massimo Bracci, Monica Amati, Adriano Tagliabracci, Simona Gaetani, Federica Alessandrini, Monaco, Federica, Gaetani, Simona, Alessandrini, Federica, Tagliabracci, Adriano, Bracci, Massimo, Valentino, Matteo, Neuzil, Jiri, Amati, Monica, Bovenzi, Massimo, Tomasetti, Marco, and Santarelli, Lory
- Subjects
Mesothelioma ,Vascular Endothelial Growth Factor A ,0301 basic medicine ,EGF Family of Proteins ,Cancer Research ,Cell signaling ,Lung Neoplasms ,Stromal cell ,miRNA-based therapy ,Carcinogenesis ,Angiogenesis ,Cell Communication ,Exosomes ,03 medical and health sciences ,0302 clinical medicine ,Stroma ,Humans ,Malignant mesothelioma ,Cells, Cultured ,Tube formation ,Cell growth ,Chemistry ,Calcium-Binding Proteins ,Mesothelioma, Malignant ,miR-126 ,Fibroblasts ,Cancer stroma ,Microvesicles ,Exosome ,MicroRNAs ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,EGFL7 ,Signal Transduction - Abstract
MiR-126 has been shown to suppress malignant mesothelioma (MM) by targeting cancer-related genes without inducing toxicity or histopathological changes. Exosomes provide the opportunity to deliver therapeutic cargo to cancer stroma. Here, a tumour stromal model composed of endothelial cells (HUVECs), fibroblasts (IMR-90 cells), non-malignant mesothelial cells (Met-5A cells) and MM cells (H28 and MM-B1 cells) was used. The cells were treated with exosomes from HUVECs carrying endogenous (exo-HUVEC) and enriched miR-126 (exo-HUVECmiR−126), and the uptake/turnover of exosomes; miR-126 distribution within the stroma; and effect of miR-126 on cell signalling, angiogenesis and cell proliferation were evaluated. Based on the sensitivity of MM cells to exo-HUVEC miR-126 treatment, miR-126 was distributed differently across stromal cells. The reduced miR-126 content in fibroblasts in favour of endothelial cells reduced angiogenesis and suppressed cell growth in an miR-126-sensitive environment. Conversely, the accumulation of miR-126 in fibroblasts and the reduced level of miR-126 in endothelial cells induced tube formation in an miR-126-resistant environment via VEGF/EGFL7 upregulation and IRS1-mediated cell proliferation. These findings suggest that transfer of miR-126 via HUVEC-derived exosomes represents a novel strategy to inhibit angiogenesis and cell growth in MM.
- Published
- 2019